JP2774071B2 - Hair restoration cosmetics - Google Patents
Hair restoration cosmeticsInfo
- Publication number
- JP2774071B2 JP2774071B2 JP6204273A JP20427394A JP2774071B2 JP 2774071 B2 JP2774071 B2 JP 2774071B2 JP 6204273 A JP6204273 A JP 6204273A JP 20427394 A JP20427394 A JP 20427394A JP 2774071 B2 JP2774071 B2 JP 2774071B2
- Authority
- JP
- Japan
- Prior art keywords
- hair
- extract
- present
- effect
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 19
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 claims description 12
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 10
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 10
- 235000002566 Capsicum Nutrition 0.000 claims description 7
- 239000006002 Pepper Substances 0.000 claims description 7
- 235000016761 Piper aduncum Nutrition 0.000 claims description 7
- 235000017804 Piper guineense Nutrition 0.000 claims description 7
- 235000008184 Piper nigrum Nutrition 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 229940098465 tincture Drugs 0.000 claims description 7
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 claims description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 6
- 229930007845 β-thujaplicin Natural products 0.000 claims description 6
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 5
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 claims description 5
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 claims description 5
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 5
- 150000002948 pantothenic acids Chemical class 0.000 claims description 5
- 150000003712 vitamin E derivatives Chemical class 0.000 claims description 5
- 244000203593 Piper nigrum Species 0.000 claims 1
- 229940008396 carrot extract Drugs 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 230000003779 hair growth Effects 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 240000004371 Panax ginseng Species 0.000 description 9
- 235000008434 ginseng Nutrition 0.000 description 9
- 235000002789 Panax ginseng Nutrition 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 6
- 241000722363 Piper Species 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 150000001996 bisabolol derivatives Chemical class 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- -1 ester compounds Chemical class 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 230000003676 hair loss Effects 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 235000015961 tonic Nutrition 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 230000003658 preventing hair loss Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 210000001732 sebaceous gland Anatomy 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- XBLVHTDFJBKJLG-UHFFFAOYSA-N Ethyl nicotinate Chemical compound CCOC(=O)C1=CC=CN=C1 XBLVHTDFJBKJLG-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000003405 preventing effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical group OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical group OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Chemical group OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- QSYCTARXWYLMOF-CBAPKCEASA-N N-[(R)-pantothenoyl]-L-cysteine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)N[C@@H](CS)C(O)=O QSYCTARXWYLMOF-CBAPKCEASA-N 0.000 description 1
- 241000967294 Swertia japonica Species 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940064982 ethylnicotinate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 230000003662 hair growth rate Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 1
- ZNXZGRMVNNHPCA-VIFPVBQESA-N pantetheine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS ZNXZGRMVNNHPCA-VIFPVBQESA-N 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 125000001020 α-tocopherol group Chemical group 0.000 description 1
- 239000011590 β-tocopherol Chemical group 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000002478 γ-tocopherol Chemical group 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical group OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- 239000002446 δ-tocopherol Chemical group 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、育毛効果、脱毛予防効
果に優れた養毛化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair nourishing cosmetic having an excellent hair-growth effect and an effect of preventing hair loss.
【0002】[0002]
【従来の技術および発明が解決しようとする課題】従来
より、トウガラシチンキおよびニコチン酸誘導体等の血
行促進物質、また毛髪の栄養成分であるアミノ酸および
ビタミン類を配合してなる養毛化粧料が知られている。
さらには、皮脂腺の肥大防止効果をもつ成分や、男性ホ
ルモンの抑制作用をもつ成分を配合する医療用養毛剤や
養毛化粧料も数多く提案されている。2. Description of the Related Art Conventionally, hair restoration cosmetics containing a blood circulation promoting substance such as pepper tincture and nicotinic acid derivatives, and amino acids and vitamins which are nutritional components of hair have been known. Have been.
Further, many medical hair restorers and cosmetics containing a component having an effect of preventing sebaceous gland hypertrophy and a component having an androgenic inhibitory effect have been proposed.
【0003】しかし、従来より使用されている血行促進
物質は、皮膚刺激が強くその配合量に制限があったり、
血行促進の持続時間が短かいという欠点がある。また、
毛髪の栄養成分も低濃度では皮膚への浸透性が低く、か
つ単独では効果が十分に発揮されないという問題点があ
る。[0003] However, conventionally used blood circulation promoting substances are highly irritating to the skin, and the amount thereof is limited,
The disadvantage is that the duration of blood circulation promotion is short. Also,
At a low concentration, the nutritional components of the hair also have a problem that the permeability to the skin is low and the effect is not sufficiently exerted by itself.
【0004】ところで、男性型脱毛症は男性ホルモンの
過剰作用が原因の一つと言われているが、血行の不良や
毛母細胞の活性低下、皮脂腺の肥大化、頭皮の線維化等
の現象が複雑に絡みあって生じていると推察されてい
る。[0004] By the way, androgenetic alopecia is said to be one of the causes of the excessive action of male hormones. Phenomena such as poor circulation, decreased activity of hair matrix cells, enlargement of sebaceous glands, fibrosis of the scalp, and the like are considered. It is presumed that it is caused by complicated intertwining.
【0005】しかし、男性ホルモンの過剰作用が原因と
いわれる毛母細胞の活性低下や皮脂腺の肥大化を抑制す
るために、単に男性ホルモン剤等を育毛剤として用いて
も、育毛作用を発現するまでには至らないのが現状であ
る。また、毛母細胞賦活剤や血行促進剤を単独で用いて
も、良好な成績は得られない。[0005] However, in order to suppress the decrease in the activity of the hair matrix and the enlargement of the sebaceous glands, which are said to be caused by the excessive action of the male hormone, even if a male hormone agent or the like is simply used as a hair restorer, the hair growth effect is not exhibited. At present. In addition, good results cannot be obtained even when the hair matrix activator or the blood circulation promoter is used alone.
【0006】前記の問題点を解決する手段として、特開
平5−58850号公報、特開平5−1399336号
公報、特開平5−170625号公報等を始めとして数
多くの養毛・育毛剤が提案されているが、末梢血流を促
進し、毛母細胞の賦活化をする物質を単独で用いても格
段の育毛作用については見出せなかった。As means for solving the above-mentioned problems, a large number of hair-growth and hair-growing agents have been proposed, including Japanese Patent Application Laid-Open Nos. 5-58850, 5-139336 and 5-170625. However, no remarkable hair-growth effect was found even when a substance that promotes peripheral blood flow and activates hair matrix cells was used alone.
【0007】本発明者らは、このような実情に鑑み、頭
皮の末梢血流の促進および毛母細胞の賦活作用のある物
質について、鋭意研究を重ねた結果、センブリエキス、
朝鮮ニンジンエキス、デュークエキス、トウガラシチン
キ、ジイソプロピルアミンジクロロアセテート、γ−ア
ミノ酪酸、ヒノキチオール、ビタミンE誘導体、パント
テン酸誘導体、ニコチン酸誘導体、グリチルリチン誘導
体等の有効成分と、ビサボロールの水素添加体を同時に
含有した養毛化粧料が、相乗効果により、優れた養毛、
育毛効果を発現することを見いだし、本発明を完成し
た。[0007] The present inventors, in view of such circumstances, the substance having a activation action of promoting and Mohaha cells of the scalp in peripheral blood flow, results of extensive studies, assembly extract,
Contains active ingredients such as Korean ginseng extract, Duke extract, Pepper tincture, diisopropylamine dichloroacetate, γ-aminobutyric acid, hinokitiol, vitamin E derivatives, pantothenic acid derivatives, nicotinic acid derivatives, glycyrrhizin derivatives, and hydrogenated bisabolol at the same time Hair nourishing cosmetics, with a synergistic effect, excellent hair nourishing,
The present inventors have found that a hair growth effect is exhibited and completed the present invention.
【0008】[0008]
【課題を解決するための手段】すなわち本発明は、セン
ブリエキス、朝鮮ニンジンエキス、デュークエキス、ト
ウガラシチンキ、ジイソプロピルアミンジクロロアセテ
ート、γ−アミノ酪酸、ヒノキチオール、ビタミンE誘
導体、パントテン酸誘導体、ニコチン酸誘導体、グリチ
ルリチン酸誘導体からなる群より選択された1種以上の
成分と、下記構造式化2That is, the present invention relates to an assembly extract, a Korean ginseng extract, a Duke extract, a pepper tincture, diisopropylamine dichloroacetate, γ-aminobutyric acid, hinokitiol, a vitamin E derivative, a pantothenic acid derivative, and a nicotinic acid derivative. And one or more components selected from the group consisting of glycyrrhizic acid derivatives;
【化2】 で示される化合物を含有することを特徴とする養毛化粧
料を提供するものである。Embedded image The present invention provides a hair restoration cosmetic comprising the compound represented by the formula (1).
【0009】以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be described in detail.
【0010】本発明に用いられる、センブリエキスはセ
ンブリ(Swertia Japonica Makino)の開花期全草の乾燥
粉砕物をエタノールあるいいは含水エタノール中で温浸
し、ろ別して得られた抽出液である。[0010] The assembly extract used in the present invention is an extract obtained by digesting a dried and ground whole plant (Swertia Japonica Makino) of the whole plant at the flowering stage in ethanol or hydrous ethanol and filtering off.
【0011】本発明に用いられる、朝鮮ニンジンエキス
は、オタネニンジン(Panax ginsengC.A.Meyer) の5〜
6年根乾燥細砕物をエタノールあるいは含水エタノール
中に冷浸し、ろ別して得られた抽出液である。The ginseng extract used in the present invention is 5 to 5 ginseng of Panax ginseng C.A. Meyer.
It is an extract obtained by cold soaking the dried ground pulverized product in ethanol or hydrous ethanol for 6 years and filtering.
【0012】本発明に用いられる、デュークエキスは、
ランジウムドメスティカムジャックバーデュークまたは
ランジウムドメスティカムジャックバーランサの果皮よ
り特開昭60−243020号公報に記載の方法により
得られる抽出物である。The Duke extract used in the present invention is:
It is an extract obtained from the skin of R. domesticum jack barduke or R. domesticum jack barrancer by the method described in JP-A-60-243020.
【0013】本発明に用いられる、トウガラシチンキ、
ジイソプロピルアミンジクロロアセテート、γ−アミノ
酪酸、ヒノキチオールは通常の化粧品原料として使用さ
れている原料が使用出来る。The pepper tincture used in the present invention,
As diisopropylamine dichloroacetate, γ-aminobutyric acid, and hinokitiol, raw materials used as ordinary cosmetic raw materials can be used.
【0014】本発明に用いられる、ビタミンE誘導体と
しては、フリーのビタミンE、またはビタミンEアセテ
ート、ビタミンEサクシネート、ビタミンEリノレー
ト、ビタミンEオロテート等のエステル化合物が典型的
な物質として使用出来る。ここで、ビタミンEはα−、
β−、γ−、δ−トコフェロールが何れも使用出来る。As the vitamin E derivative used in the present invention, free vitamin E or ester compounds such as vitamin E acetate, vitamin E succinate, vitamin E linoleate and vitamin E orotate can be used as typical substances. Here, vitamin E is α-,
β-, γ-, and δ-tocopherol can be used.
【0015】本発明に用いられる、パントテン酸誘導体
としては、フリーのパントテン酸、パントテニルアルコ
ール、パントテニルエチルエーテル、アセチルパントテ
ニルエチルエーテル、ベンゾイルパントテニルエチルエ
ーテル、D−パンテサイン、D−パンテチン、D−パン
トテノイル−L−システイン、ジ−D−パントテノイル
−L−システイン等の一連の化合物が挙げられる。[0015] The pantothenic acid derivatives used in the present invention include free pantothenic acid, pantothenyl alcohol, pantothenyl ethyl ether, acetyl pantothenyl ethyl ether, benzoyl pantothenyl ethyl ether, D-pantetheine, D-pantethine, A series of compounds such as D-pantothenoyl-L-cysteine and di-D-pantothenoyl-L-cysteine are exemplified.
【0016】本発明に用いられる、ニコチン酸誘導体と
しては、ニコチン酸、ニコチン酸アミド、またはニコチ
ン酸エステルであり、エステルとしては例えばニコチン
酸−α−トコフェロール、ニコチン酸ベンジル、ニコチ
ン酸メチル、ニコチン酸エチル等の化合物が使用でき
る。The nicotinic acid derivative used in the present invention is nicotinic acid, nicotinamide or nicotinic acid.
For example, compounds such as nicotinic acid-α-tocopherol, benzyl nicotinate, methyl nicotinate, and ethyl nicotinate can be used as the ester.
【0017】本発明に用いられる、グリチルリチン酸誘
導体としては、グリチルリチン酸、グリチルリチン酸ジ
カリウム、グリチルリチン酸モノアンモニウム、β−グ
リチルレチン酸、グリチルレチン酸ステアリル、等の化
合物が使用出来る。As the glycyrrhizic acid derivative used in the present invention, compounds such as glycyrrhizic acid, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, β-glycyrrhetinic acid, and stearyl glycyrrhetinate can be used.
【0018】本発明に用いられる、ビサボロールの水素
添加体は、前記構造式化2で示され、抽出法、製造法は
特に問わない。また、該化合物には立体異性体が存在す
るが、何れか単独または2種以上の混合物でも差し支え
ない。本化合物は、たとえば、α−ビサボロールをZ.
Naturforsch.,C:Biosci.,46
(5−6)、349−356(1991)に記載されて
いる、Hashidokoらの方法を用いて調製出来
る。本発明に用いるビサボロールの水素添加体を、以下
水添ビサボロールという。The hydrogenated bisabolol used in the present invention is represented by the above structural formula 2, and the extraction method and production method are not particularly limited. The compound has stereoisomers, but any one of them or a mixture of two or more thereof may be used. The present compound can be obtained, for example, by converting α-bisabolol to Z.
Natureforsch. , C: Biosci. , 46
(5-6), 349-356 (1991), and can be prepared using the method of Hashidoko et al. The hydrogenated bisabolol used in the present invention is hereinafter referred to as hydrogenated bisabolol.
【0019】本発明に用いられる水添ビサボロールの配
合量は、特に限定されるものではないが、養毛化粧料の
総量を基準に0.01〜20重量%(以下、wt%と略
する)が好ましい。The amount of the hydrogenated bisabolol used in the present invention is not particularly limited, but is 0.01 to 20% by weight (hereinafter abbreviated as wt%) based on the total amount of the hair growth cosmetic. Is preferred.
【0020】本発明に用いられる、センブリエキス、朝
鮮ニンジンエキスおよびデュークエキスの配合量は、養
毛化粧料の総量を基準として、乾燥残分に換算して、
0.001〜10.0wt%が好ましく、より好ましく
は0.01〜5.0wt%である。The amounts of the assembly extract, Korean ginseng extract and Duke extract used in the present invention are calculated as a dry residue based on the total amount of the hair growth cosmetic.
The content is preferably 0.001 to 10.0 wt%, more preferably 0.01 to 5.0 wt%.
【0021】本発明に用いられる、トウガラシチンキ、
ジイソプロピルアミンジクロロアセテート、γ−アミノ
酪酸、ヒノキチオール、ビタミンE誘導体、パントテン
酸誘導体、ニコチン酸誘導体、グリチルリチン酸誘導体
の配合量は、養毛化粧料の総量を基準として、0.00
1〜5.0wt%が好ましく、より好ましくは0.01
〜2.0wt%である。The pepper tincture used in the present invention,
The compounding amount of diisopropylamine dichloroacetate, γ-aminobutyric acid, hinokitiol, vitamin E derivative, pantothenic acid derivative, nicotinic acid derivative, and glycyrrhizic acid derivative is 0.00% based on the total amount of the hair growth cosmetic.
The content is preferably 1 to 5.0 wt%, more preferably 0.01 wt%.
~ 2.0 wt%.
【0022】本発明の養毛化粧料は、常法に従って、た
とえばヘアートニック、ヘアーローション、ヘアークリ
ーム、ヘアーコンディショナー、シャンプー、リンス、
ヘアージェル、ヘアーミスト、ヘアーフォーム等の剤型
に製造し、使用することが可能である。The hair nourishing cosmetic composition of the present invention may be used in accordance with a conventional method, for example, for hair tonic, hair lotion, hair cream, hair conditioner, shampoo, rinse,
It can be manufactured and used in dosage forms such as hair gel, hair mist, and hair foam.
【0023】本発明の養毛化粧料は、養毛、育毛および
/または脱毛予防のために、それを目的とする局所(頭
皮)に、その剤型に従って塗布または噴霧して適用され
る。The hair growth cosmetic composition of the present invention is applied or sprayed to a topical area (scalp) for the purpose of hair growth, hair growth and / or hair loss prevention according to the dosage form.
【0024】なお、本発明の養毛化粧料には、色素、香
料、殺菌剤、防腐剤、角質溶解剤、抗アンドロゲン剤、
抗酸化剤等を本発明の目的を達成する範囲で適宜配合す
ることができる。The hair nourishing cosmetic composition of the present invention includes a pigment, a fragrance, a bactericide, a preservative, a keratolytic agent, an antiandrogen,
An antioxidant and the like can be appropriately compounded within a range that achieves the object of the present invention.
【0025】[0025]
【実施例】以下、実施例および比較例により本発明を詳
細に説明するが、本発明はこれらに限定されるものでは
ない。なお、本発明に使用した試験方法は下記の通りで
ある。The present invention will be described in detail below with reference to examples and comparative examples, but the present invention is not limited to these examples. The test method used in the present invention is as follows.
【0026】(1)マウス毛成長促進効果試験法 C3H系マウス(雄・8週齢・平均体重35g)の背部
中央の皮膚を電気バリカンで刈った後、シェーバーによ
り完全に除毛した。翌日より実施例および比較例の各試
料を被験部皮膚に毎日1回、一匹当り0.2ml塗布し
た。一試料に対して動物は一群10匹を使用した。な
お、対照群として基剤単独を塗布した。実験開始後14
日目に動物を屠殺し、被験部皮膚の写真撮影を行なっ
た。つぎに、写真を画像解析装置に取り込み、最初に毛
刈りした面積(A)と、発毛面積(B)を求め、さらに 発毛率(%)=〔(B)/(A)〕×100 を個々の動物について算出した。最後に、実施例または
比較例の各群の平均値を対照群の平均値により除した値
を毛成長促進効果として判定に用いた。(1) Mouse Hair Growth Promotion Effect Test Method The skin at the center of the back of a C3H mouse (male, 8 weeks old, average body weight: 35 g) was cut with an electric clipper, and the hair was completely removed with a shaver. From the next day, each sample of Example and Comparative Example was applied to the skin of the test part once a day, 0.2 ml per animal. A group of 10 animals was used for one sample. The base alone was applied as a control. 14 after the start of the experiment
On the day, the animals were sacrificed and the skin of the test area was photographed. Next, the photograph was taken into an image analyzer, and the area (A) of initial shaving and the area of hair growth (B) were determined. Further, the hair growth rate (%) = [(B) / (A)] × 100 Was calculated for each animal. Finally, the value obtained by dividing the average value of each group of the examples or comparative examples by the average value of the control group was used as a hair growth promoting effect in the determination.
【0027】(2)実用試験法 男性型脱毛症患者20名の頭部に毎日朝夕2回、連続6
ケ月間試料を塗布した後の効果を評価した。試験結果
は、育毛効果、および脱毛予防効果の各項に対して、
「生毛が剛毛化した或は剛毛が増加した」、「脱毛が少
なくなった」と回答した人数で示した。(2) Practical test method Twice in the morning and evening twice a day on the head of 20 male pattern baldness patients
The effect after applying the sample for a month was evaluated. The test results are for hair growth and hair loss prevention.
The number of respondents who answered "the hair has become bristle or has increased bristles" and "the hair loss has decreased" are shown.
【0028】(3)各有効成分の製造法 実施例に用いるセンブリエキス、朝鮮ニンジンエキスお
よびデュークエキスの製造法に関しては特定されるもの
ではないが、各々の製造方法の概要を以下に記載する。
トウガラシチンキ、ヒノキチオール等の成分は、通常の
化粧品原料として用いられているものを試料とした。(3) Production method of each active ingredient The production methods of the assembly extract, Korean ginseng extract and Duke extract used in the examples are not specified, but the outline of each production method is described below.
As components such as pepper tincture and hinokitiol, those used as ordinary cosmetic raw materials were used as samples.
【0029】〔センブリエキスの製造法〕センブリ細砕
物50g を含水エタノール(エタノール50wt%)2
50mlに温度40〜50°Cで温浸した後、再び残さを
同様に温浸することをくり返し、抽出液1.5リットル
を得た。これを減圧濃縮した残留物に精製水を100ml
加え、一週間熟成した後、不溶部をろ別して得た抽出液
を減圧濃縮し、ついでエタノールを加えて抽出液のエタ
ノール含有量が50wt%になるように調整し、100
mlのセンブリエキスを得た。[Production method of assembly extract] 50 g of milled assembly was added to aqueous ethanol (ethanol 50 wt%) 2
After digestion in 50 ml at a temperature of 40 to 50 ° C., the residue was digested again to obtain 1.5 liter of extract. This was concentrated under reduced pressure, and 100 ml of purified water was added to the residue.
In addition, after aging for one week, the extract obtained by filtering off the insoluble portion was concentrated under reduced pressure, and then ethanol was added to adjust the extract to have an ethanol content of 50% by weight.
ml of assembly extract was obtained.
【0030】〔朝鮮ニンジンエキスの製造法〕オタネニ
ンジンの5〜6年根乾燥細砕物50g を含水エタノール
(エタノール50wt%)200mlに1週間冷浸し、ろ
別して得られた抽出液のエタノールを留去し、精製水を
加えて抽出液のエタノール含有量が50wt%になるよ
うに調整し、さらにこれを7〜10週間冷所で熟成した
後、ろ別して100mlの朝鮮ニンジンエキスを得た。[Production method of Korean ginseng extract] 50 g of dried ginseng of Panax ginseng in 5 to 6 years was cold-immersed in 200 ml of aqueous ethanol (50 wt% of ethanol) for 1 week, and the ethanol of the extract obtained by filtration was distilled off. Then, purified water was added to adjust the ethanol content of the extract to 50 wt%, and the extract was aged in a cool place for 7 to 10 weeks, and then filtered to obtain 100 ml of a ginseng extract.
【0031】〔デュークエキスの製造法〕デュークエキ
スは、ランジウムドメスティカムジャックバーデューク
の果皮50g を粉砕し、エタノール200mlに浸し、1
週間室温に放置した。さらに、混合物をろ過し、減圧濃
縮して油状物質5.2g を得た。[Manufacturing Method of Duke Extract] Duke extract is prepared by crushing 50 g of Randium domesticum jack barduke peel and immersing it in 200 ml of ethanol.
Left at room temperature for a week. Further, the mixture was filtered and concentrated under reduced pressure to obtain 5.2 g of an oily substance.
【0032】以下本文中では、上記の如く50%エタノ
ール水溶液にて抽出して得られるエキスの純分(乾燥残
分で換算)を基準として配合量を表示する。In the following text, the compounding amount is indicated on the basis of the pure content (converted to the dry residue) of the extract obtained by extraction with the 50% aqueous ethanol solution as described above.
【0033】実施例1〜13、比較例1〜13(ヘアー
トニック) 表1の原料組成において、表2に記載の如く有効成分を
配合してヘアートニックを調製し、前記の諸試験を実施
した。なお、表中の%は重量%を示す。Examples 1 to 13 and Comparative Examples 1 to 13 (Heart Tonic) Hair tonics were prepared by blending active ingredients as shown in Table 2 in the raw material composition shown in Table 1, and the above-mentioned various tests were carried out. . Incidentally,% in the table indicates% by weight.
【0034】[0034]
【表1】 [Table 1]
【0035】[0035]
【表2】 [Table 2]
【0036】(1)調製法 表1に記載の(B)成分を(A)成分中に溶解させた
後、(C)成分を添加し、混合攪拌分散して容器に充填
した。使用時には内容物を均一に振盪分散して使用し
た。(1) Preparation Method After dissolving the component (B) shown in Table 1 in the component (A), the component (C) was added, and the mixture was stirred, dispersed and filled into a container. At the time of use, the contents were uniformly shaken and used.
【0037】(2)特性 各ヘアートニックの諸試験を実施した結果を表2に示し
た。表2の通り、比較例1〜13はマウス毛成長促進効
果およびヒト抜け毛改善効果が低く、実用試験の結果も
良好ではなかった。(2) Characteristics Table 2 shows the results of various tests performed on each hair tonic. As shown in Table 2, Comparative Examples 1 to 13 had low mouse hair growth promoting effect and human hair loss improving effect, and the results of practical tests were not good.
【0038】一方、実施例1〜13の本発明の養毛化粧
料は、高いマウス毛成長促進効果およびヒト抜け毛改善
効果を示し、さらに実用試験の結果も良好であり、諸試
験の全てにわたって明らかに良好な結果を示した。な
お、いずれの実施例の養毛化粧料を用いた場合にも、マ
ウスおよびヒトに炎症その他副作用と考えられる症状は
発現せず、本発明の養毛化粧料は安全性にも優れること
が明らかであった。On the other hand, the hair restoration cosmetics of the present invention of Examples 1 to 13 show high mouse hair growth promoting effect and human hair loss improving effect, and the results of practical tests are also good. Showed good results. In addition, when using the hair restoration cosmetics of any of the examples, inflammation and other symptoms considered to be side effects do not occur in mice and humans, and it is clear that the hair restoration cosmetics of the present invention are also excellent in safety. Met.
【0039】[0039]
【発明の効果】本発明の養毛化粧料は、毛母細胞の賦活
化作用を有し、育毛効果、脱毛予防効果および安全性に
優れる。EFFECT OF THE INVENTION The hair restoration cosmetic of the present invention has an effect of activating hair matrix cells, and is excellent in hair growth effect, hair loss preventing effect and safety.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) A61K 7/00 - 7/155 CA(STN) REGISTRY(STN) WPIDS(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int. Cl. 6 , DB name) A61K 7/00-7/155 CA (STN) REGISTRY (STN) WPIDS (STN)
Claims (1)
デュークエキス、トウガラシチンキ、ジイソプロピルア
ミンジクロロアセテート、γ−アミノ酪酸、ヒノキチオ
ール、ビタミンE誘導体、パントテン酸誘導体、ニコチ
ン酸誘導体、グリチルリチン酸誘導体からなる群より選
択された少なくとも1種以上の成分と、下記構造式 【化1】 で表される化合物を含有することを特徴とする養毛化粧
料。1. An assembly extract, a Korean carrot extract,
Duke extract, pepper tincture, diisopropylamine dichloroacetate, γ-aminobutyric acid, hinokitiol, vitamin E derivative, pantothenic acid derivative, nicotinic acid derivative, glycyrrhizic acid derivative and at least one or more components selected from the group consisting of: Formula 1 A hair restoration cosmetic comprising the compound represented by the formula:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6204273A JP2774071B2 (en) | 1994-08-05 | 1994-08-05 | Hair restoration cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6204273A JP2774071B2 (en) | 1994-08-05 | 1994-08-05 | Hair restoration cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0848616A JPH0848616A (en) | 1996-02-20 |
| JP2774071B2 true JP2774071B2 (en) | 1998-07-09 |
Family
ID=16487752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6204273A Expired - Fee Related JP2774071B2 (en) | 1994-08-05 | 1994-08-05 | Hair restoration cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2774071B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962523A (en) * | 1996-10-25 | 1999-10-05 | Discovery Laboratories, Inc. | Methods of using butyric acid derivatives to protect against hair loss |
| ITMO20020363A1 (en) * | 2002-12-19 | 2004-06-20 | Maria Grazia Canalini | HAIR CARE LOTION. |
| JP4469617B2 (en) * | 2004-01-16 | 2010-05-26 | 花王株式会社 | Hair restoration |
-
1994
- 1994-08-05 JP JP6204273A patent/JP2774071B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0848616A (en) | 1996-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000226317A (en) | Hair lotion having improved properties in hair-protecting action, hair reduction-preventing action and action for lowering external action of androgenic alopecia and the resulting hair damage | |
| JP3597210B2 (en) | Hair restoration | |
| JP2977648B2 (en) | Hair restoration cosmetics | |
| JP3014214B2 (en) | Hair restoration cosmetics | |
| JP2774071B2 (en) | Hair restoration cosmetics | |
| JPH0327524B2 (en) | ||
| JP3045613B2 (en) | Hair restoration cosmetics | |
| JP2000109417A (en) | Cosmetic for improving somber color | |
| JP3464591B2 (en) | Hair restoration cosmetics | |
| JP2546813B2 (en) | Hair nourishing cosmetics | |
| JP3534959B2 (en) | Hair restoration cosmetics | |
| JP2001131031A (en) | Composition for scalp and hair | |
| JP2002080327A (en) | Hair grower | |
| JP3133532B2 (en) | Hair restoration cosmetics | |
| JP2994993B2 (en) | Hair restoration cosmetics | |
| JP2001342145A (en) | Hair restorer and ulcer healing agent | |
| JPS61171413A (en) | Hair tonic | |
| JP3382148B2 (en) | External preparation for head | |
| JP3014215B2 (en) | Hair restoration cosmetics | |
| JPH1077216A (en) | Hair-restoring cosmetic material | |
| JP3193544B2 (en) | Hair restoration cosmetics | |
| JP2004026812A (en) | Hair restoration | |
| JP2000016920A (en) | Hair tonic cosmetic | |
| JPS63196507A (en) | Hair nourishing cosmetic | |
| JPS62103005A (en) | Hair tonic cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080424 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090424 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090424 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100424 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110424 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120424 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130424 Year of fee payment: 15 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130424 Year of fee payment: 15 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140424 Year of fee payment: 16 |
|
| LAPS | Cancellation because of no payment of annual fees |